Visionary Leaders Join the Team Behind MenoTime, the First and Only Time-to-Menopause Predictor and Ovarian Age Clock
Timeless Biotech, an ovarian longevity company is proud to announce the appointment of Allie Egan and Alisa Marie Beyer to its Board of Directors.
With deep expertise in women’s health, consumer innovation, and business leadership, Egan and Beyer bring unmatched strategic insight to help Timeless Biotech scale its science-backed platform that is transforming the future of female longevity and hormone health.
“We are thrilled to welcome Allie and Alisa to our board,” said Kiran Kumar, CEO and Founder of Timeless Biotech. “Their experience will be invaluable as we expand MenoTime’s reach and redefine how women proactively manage their hormonal health and ovarian longevity.”
Meet the New Directors:
Allie Egan is a seasoned executive and founder of the science-forward metabolic health company Veracity. Egan is listed as a Inc. 500 Female Founder and Forbes 1000 Honoree. Egan was previously CEO of Cynthia Rowley and a growth-stage investor at L Catterton.
Alisa Marie Beyer is a serial entrepreneur with over two decades of experience building and scaling female-focused brands. She is the founder of LUX Beauty Group, which was successfully acquired, and the former CEO of SpaRitual. A lifelong advocate for women’s whole-life health, Alisa has worked at every stage of the female journey.
About Timeless Biotech
Timeless Biotech is defining the category of ovarian longevity with the first-ever time-to-menopause predicting model and ovarian age clock. Our model will enable women to track and hack ovarian aging, arguably the largest contributor to female longevity. Powered by a proprietary machine learning model, Timeless Biotech is bringing actionable data and insights to women’s health.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.